The transition from Go phase, a quiescent, nongrowing state, to G1 phase of the cell cycle is the first of several steps preceding the initiation ofDNA synthesis. In nontransformed cells, the binding of extracellular growth factors to their plasma membrane receptors is required for this transition (1) . Subsequent steps in G1 include the activation of intracellular second messengers, kinases, and early response genes (2) . At the G1/S boundary, the final molecular events regulating the onset of DNA synthesis occur (3) and during S phase a complete copy of the genome is made (4) . When compared to nontransformed cells, transformed cells are often less dependent on growth factors (5, 6) or they can have altered regulation of second messengers, kinases (7) , and early response genes (8) .
Since a cell coordinately regulates initiation at many sites of DNA replication (9) at the start of S phase (10, 11) , the molecular events at the G1/S boundary are of particular interest. Kinetic experiments showed that reduction of serum levels or inhibition of protein synthesis before a restriction point in late G1 prevented or lengthened the time of entry to S in nontransformed cells (10) . However, after this restriction point, the transit from G1 to S was insensitive to serum deprivation and protein synthesis inhibition (10) . Based on these results and others (11, 12) , we proposed that the level of a regulatory protein passes above a critical threshold at the restriction point and commits a cell to DNA synthesis (13) . Protein synthesis inhibition and serum deprivation lengthen the time of G1 because the protein is unstable under these conditions and cannot reach the critical threshold level.
A major difference was observed in transformed cells: the duration of G1 was not lengthened by protein synthesis inhibition or serum deprivation (11, 14) . Hypothetically, the protein is stabilized in transformed cells and is able to reach its critical threshold level despite serum deprivation or protein synthesis inhibition.
Recently, we have used a "reverse approach" to study the regulatory events in late G1 (15) . Instead of following the molecular events sequentially after stimulation with growth factors, one works backwards by studying the regulation of the early molecular events of S phase (15) . Thymidine kinase was chosen as a model system for the reverse approach because its activity and its mRNA increase coordinately with DNA synthesis (16) , and these increases are blocked by partial inhibition of protein synthesis, as is DNA synthesis (17) .
Thymidine kinase gene expression is regulated by both transcriptional and posttranscriptional mechanisms (16, 18, 19) . Deletion analysis performed on the mouse thymidine kinase promoter indicated that a region between 24 and 174 bases upstream from the translation start site was essential for expression of reporter genes (J.L.F.-K., unpublished data). When DNase I footprint and mobility-shift DNA binding assays with nuclear extracts prepared from nontransformed A31 cells were used, a binding activity to a consensus sequence located in three binding sites (MT1, MT2, and MT3) of this region was found (21) . Designated Yi, the DNA binding activity was absent in quiescent cells but present during late G1 and S phases (21 Then cells were rinsed once with Dulbecco's modified Eagle's medium and Dulbecco's modified Eagle's medium was added with 0.2% bovine calf serum for 96 hr (BPA31 cells) or 0.4% bovine calf serum for 60 hr (A31 cells). Under these conditions, both A31 and BPA31 cells became growth arrested as determined by [methyl-3H]thymidine incorporation rates (see below). After growth arrest, serum levels were increased to 10% and cells proceeded through the cell cycle.
DNA and Protein Synthesis Rate Determination. Cultures parallel to those in 150-cm2 dishes were grown in 24-well plates to measure DNA and protein synthesis rates. After growing cells initially plated at 5 x 103 cells per well, the number of cells per cm2 of plating area was indistinguishable from the 150-cm2 dishes.
DNA synthesis rates were monitored by first adding [methyl-3H]thymidine (4 ttCi/ml; 1 Ci = 37 GBq) to individual wells and stopping incorporation after 1 hr with 150 mM (final concentration) ascorbic acid. After at least 10 min in ascorbic acid, wells were rinsed twice with cold phosphatebuffered saline (40C), rinsed once with MeOH, fixed in MeOH at room temperature for 15 min, and allowed to air dry. After incubation with 0.2 M NaOH at 37°C overnight, wells were processed for scintillation counting.
Protein synthesis rates were measured by adding 10-20 Preparation of Nuclear Extracts and Mobility-Shift DNA Binding Assays. Nuclear extracts were prepared as described (27) by Dounce homogenizing cells while in buffer I (10 mM Hepes, pH 7.9/1.5 mM MgCl2/10 mM KCI/0.3 M sucrose/ 0.1 mM EGTA/0.5 mM dithiothreitol/0.5 mM phenylmethylsulfonyl fluoride), pelleting nuclei after spinning 30 min in an Eppendorf centrifuge (model 5415, top speed), extracting pellets in buffer II [20 mM Hepes, pH 7.9/25% (vol/vol) glycerol/0.42 M NaCl/1.5 mM MgCl2/0.2 mM EDTA/0.1 mM EGTA/0.5 mM dithiothreitol/0.5 mM phenylmethylsulfonyl fluoride], spinning again in an Eppendorf centrifuge, and finally dialyzing the supernatant against buffer III (20 mM Hepes, pH 7.9/20% glycerol/100 mM KCl/0.2 mM EDTA/0.5 mM dithiothreitol/0.5 mM phenylmethylsulfonyl fluoride).
The synthetic MT1 oligonucleotide 5'-TCGAGTCT-TCGTCCCGCCCCCTTTT-3', which contains the MT1 sequence of the murine thymidine kinase promoter (21) , was hybridized to its complement and end-labeled with deoxycytidine 5'-[a-32P]triphosphate by using the Klenow fragment of DNA polymerase to a specific activity of 1-10 x 105 cpm/ng. Levels of Yi binding activity in nuclear extracts were measured with the mobility-shift DNA binding assay (20) by adding saturating amounts of end-labeled MT1 oligonucleotide (=100,000 cpm; =0.5 ng) to 20 gg of nuclear extract in the presence of poly(dFdC) (0.05 mg/ml) as a nonspecific competitor. Samples were electrophoresed through 4% polyacrylamide at 170 V. Polyacrylamide gels were fixed and dried, and XAR-5 Kodak film was exposed at -70°C for [1] [2] [3] [4] [5] days.
To test the mobility-shift DNA binding assay for linearity, the MT1 oligonucleotide was added to increasing amounts of nuclear extracts (up to 25 gg) and Yi binding activity was measured. A linear relationship existed between the intensities of the Yi bands and the amounts of extracts used. prepared from exponentially growing cells and at half-day intervals after serum levels were reduced. Yi binding activity, as determined by the mobility-shift DNA binding assay, decreased to undetectable levels 1 day after serum withdrawal for A31 cells (Fig. 1) . In contrast, high levels of Yi binding activity were detected throughout a 4-day period of serum starvation for BPA31 cells (Fig. 1 ). This disappearance of Yi binding activity in serum-starved A31 cells and its persistence in serum-starved BPA31 cells was observed in multiple experiments. The top two bands in the mobility-shift DNA binding assay are labeled as SP1 (Fig. 1) because experiments with an SP1 consensus site and point mutation suggest that these two bands are due to a murine SPi-like activity (21) . These bands remained relatively constant through all these experiments, serving as an internal control to demonstrate that equal amounts of nuclear extracts were used for each lane. As a control for growth arrest, [methyl-3H]thymidine incorporation rates were measured in parallel cultures of cells at half-day intervals over the same 4-day period. After 2.5 days of serum starvation, the rates of [methyl-3H]thymidine incorporation decreased 50-fold for BPA31 cells (to 0.0075 cpm per cell per hr) and decreased 10-fold for A31 cells (to 0.02 cpm per cell per hr).
RESULTS
Yi Binding Activity in Transformed Cells After Serum Stimulation. A31 and BPA31 cells were synchronized as described in Materials and Methods. Nuclear extracts from cells were prepared at the indicated times (Fig. 2) after serum levels were increased, and Yi binding activity was measured by the mobility-shift DNA binding assay. The detailed appearance of Yi binding activity in A31 cells at late G1 and S phases has been reported elsewhere (21) and is shown here as a control (Fig. 2) . In contrast to A31 cells, the levels of Yi binding activity for BPA31 cells was always detected during serum starvation and was at higher levels within 4 hr after serum stimulation (Fig. 2) . data not shown) . It has been shown that cycloheximide inhibits protein synthesis in A31 cells and BPA31 cells equally and that the inhibition occurs within 10 min after it is added (11) . Yi binding activity in A31 cells was dramatically reduced by 4 hr after protein synthesis inhibition (Fig.  3) . A similar drop-offin Yi binding activity was also observed when cycloheximide was applied to A31 cells 12 or 17 hr after serum stimulation (data not shown). The SP1-like binding activity remained constant, demonstrating that the effect of cycloheximide on Yi binding is not a general phenomenon applicable to all DNA binding activities.
In BPA31 cells, Yi binding activity remained constant for at least 7 hr after application of cycloheximide (Fig. 3) . Since BPA31 cells progress from Go to S phase 1.5-2 hr faster than A31 cells (23) , cycloheximide was also added to BPA31 cells 12 hr after serum stimulation. Identical results were obtained (data not shown).
Partial Inhibition of Protein Synthesis in Nontransformed
Cells Blocks Appearance ofYi Binding Activity. In controls, Yi binding activity increased between 8 and 14 hr after serum stimulation (Fig. 4) . Cycloheximide was applied to A31 cells 8 hr after serum stimulation, and Yi binding activity was assayed at 14 hr. The increase in Yi binding activity was blocked by cycloheximide (0.1 ,g/ml) (Fig. 4) . This low level of cycloheximide inhibited protein synthesis by 60-80% and blocked DNA synthesis by >90%o (data not shown) as reported (10) . The strong effects of low concentrations of cycloheximide on the induction of Yi binding were seen in multiple experiments.
DISCUSSION
Previous kinetic experiments demonstrated that reduced serum levels and inhibition of protein synthesis prevented DNA synthesis only if applied before a restriction point in late G1 (10) . The labile protein model proposed that high serum levels and high protein synthesis rates enabled a critical quantity of an unstable, regulatory protein to be synthesized at the restriction point (10 (11, 14) . Accordingly, we expected the hypothetical regulatory protein to be stable in transformed cells. Stability was monitored under the same conditions used for nontransformed cells-serum deprivation and protein synthesis inhibition. During serum starvation, Yi binding activity was more stable in transformed BPA31 cells (Fig. 1 ). This could be caused by a longer half-life for the protein complex or by continued synthesis. Also, during strong inhibition of protein synthesis Yi binding activity was more stable in transformed BPA31 cells (Fig. 3) . Two other proteins that are stabilized in transformed cells are p68 (24) and p53 (25) Interestingly, the abrupt decrease of Yi binding activity in S-phase A31 cells treated with cycloheximide (Fig. 3) was not observed for exponentially growing cycling A31 cells (data not shown). This may reflect a difference in the regulation of S phases of constantly cycling cells as opposed to cells immediately after serum stimulation. The sharpness of the drop-off is most likely due to the type of molecular interactions. For example, reduction in levels of one overabundant component of a cooperative complex could result in these kinetics.
Yi binding activity is present in serum-starved BPA31 cells, in which both thymidine kinase activity and DNA synthesis rates are at low levels. This observation does not prove that the function of Yi binding activity is unrelated to thymidine kinase activity and/or DNA synthesis. As outlined in the Introduction, there are several levels of regulation for DNA synthesis, as there are for thymidine kinase. Since transformed BPA31 cells have an increase of thymidine kinase activity and DNA synthesis rates at S phase, some of these levels of control must persist after transformation. The regulation of gene expression for thymidine kinase in A31 and BPA31 cells can be used as a model system to determine which levels of control remain intact and which levels are deregulated in transformed cells.
In addition to the studies on stability of Yi binding activity, we also have shown that the kinetics of Yi appearance after serum stimulation vary between transformed cells and nontransformed cells. Similar differences between transformed and nontransformed cells in binding activities to the histone promoter have been observed (26 
